# Ultiva

NDC: 72078-034
Generic name: Remifentanil Hydrochloride
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230621

FDA application: NDA020630

## Active ingredients

- REMIFENTANIL HYDROCHLORIDE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72078-034"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72078-034
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b4c8696-e23e-4c51-a4d2-babab5bd945a